MAPT and proteostasis deficiencies: Based on studies showing that reducing disease protein levels can rescue neurodegeneration in other proteinopathy models (Moreno et al., 2012; Park et al., 2013), we tested whether decreasing TRIM28 would mitigate the phenotypes resulting from overexpression of either α-Syn or tau.